Announcements Trials
Browse Landscape

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Breast 1

Conditions

Carcinoma, Intraductal, Noninfiltrating 1Breast Neoplasms 1Breast Carcinoma In Situ 1

Interventions

Tamoxifen 3Mastectomy, Segmental 2Immunohistochemistry 2talimogene laherparepvec 1abemaciclib 1Surgical Procedures, Operative 1Sugars 1Specimen Handling 1Radiotherapy 1Radiation 1Nivolumab 1Naltrexone 1Mass Spectrometry 1Lovastatin 1Ipilimumab 1Infliximab 1Hypericum extract LI 160 1Genotype 1Gels 1Gefitinib 1Fluorescent Antibody Technique 1Flow Cytometry 1Chromatography, Liquid 1Chemotherapy, Adjuvant 1Celecoxib 1CTLA-4 Antigen 1Brachytherapy 1Biopsy, Needle 1Biopsy, Fine-Needle 1Biopsy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Breast Carcinoma In Situ × Genotype × Clear all
NCT05755269 2026-05-01

Adding a Genetic Risk Evaluation to Standard Breast Cancer Risk Assessment for African American and Hispanic Women

Mayo Clinic

Terminated
19 enrolled
Breast

Breast Carcinoma In Situ, Breast Neoplasms, Carcinoma, Intraductal, Noninfiltrating

Data powered by HemOnc (CC BY 4.0) Colophon âš¡